CeNeS, GlaxoSmithKline deal

CeNeS will issue 120,752 shares to GlaxoSmithKline as part of a 2003 deal under which CeNeS acquired CNS 7056 and associated compounds from the pharma company. The payment is valued at £36,000 ($71,8...